6-31530198-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001011700.3(MCCD1):c.*263T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0954 in 781,844 control chromosomes in the GnomAD database, including 4,309 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.077 ( 609 hom., cov: 31)
Exomes 𝑓: 0.10 ( 3700 hom. )
Consequence
MCCD1
NM_001011700.3 3_prime_UTR
NM_001011700.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.73
Publications
22 publications found
Genes affected
MCCD1 (HGNC:20668): (mitochondrial coiled-coil domain 1) Predicted to be located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
DDX39B (HGNC:13917): (DExD-box helicase 39B) This gene encodes a member of the DEAD box family of RNA-dependent ATPases that mediate ATP hydrolysis during pre-mRNA splicing. The encoded protein is an essential splicing factor required for association of U2 small nuclear ribonucleoprotein with pre-mRNA, and it also plays an important role in mRNA export from the nucleus to the cytoplasm. This gene belongs to a cluster of genes localized in the vicinity of the genes encoding tumor necrosis factor alpha and tumor necrosis factor beta. These genes are all within the human major histocompatibility complex class III region. Mutations in this gene may be associated with rheumatoid arthritis. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on both chromosomes 6 and 11. Read-through transcription also occurs between this gene and the upstream ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) gene. [provided by RefSeq, Feb 2011]
ATP6V1G2-DDX39B (HGNC:41999): (ATP6V1G2-DDX39B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) and DDX39B (DEAD box polypeptide 39B) genes located in the major histocompatibility complex class III region of chromosome 6. The read-through transcript and is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCCD1 | NM_001011700.3 | c.*263T>C | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000376191.3 | NP_001011700.2 | ||
DDX39B | NM_004640.7 | c.*236A>G | downstream_gene_variant | ENST00000396172.6 | NP_004631.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCCD1 | ENST00000376191.3 | c.*263T>C | 3_prime_UTR_variant | Exon 2 of 2 | 1 | NM_001011700.3 | ENSP00000365362.2 | |||
DDX39B | ENST00000396172.6 | c.*236A>G | downstream_gene_variant | 1 | NM_004640.7 | ENSP00000379475.1 | ||||
ATP6V1G2-DDX39B | ENST00000376185.5 | n.*1737A>G | downstream_gene_variant | 2 | ENSP00000365356.1 |
Frequencies
GnomAD3 genomes AF: 0.0770 AC: 11694AN: 151888Hom.: 611 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
11694
AN:
151888
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0999 AC: 62902AN: 629838Hom.: 3700 Cov.: 8 AF XY: 0.0977 AC XY: 31314AN XY: 320584 show subpopulations
GnomAD4 exome
AF:
AC:
62902
AN:
629838
Hom.:
Cov.:
8
AF XY:
AC XY:
31314
AN XY:
320584
show subpopulations
African (AFR)
AF:
AC:
241
AN:
15434
American (AMR)
AF:
AC:
957
AN:
17278
Ashkenazi Jewish (ASJ)
AF:
AC:
1970
AN:
14464
East Asian (EAS)
AF:
AC:
107
AN:
31274
South Asian (SAS)
AF:
AC:
1627
AN:
45716
European-Finnish (FIN)
AF:
AC:
4660
AN:
36802
Middle Eastern (MID)
AF:
AC:
246
AN:
2292
European-Non Finnish (NFE)
AF:
AC:
49936
AN:
435156
Other (OTH)
AF:
AC:
3158
AN:
31422
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2867
5734
8602
11469
14336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0769 AC: 11691AN: 152006Hom.: 609 Cov.: 31 AF XY: 0.0760 AC XY: 5647AN XY: 74282 show subpopulations
GnomAD4 genome
AF:
AC:
11691
AN:
152006
Hom.:
Cov.:
31
AF XY:
AC XY:
5647
AN XY:
74282
show subpopulations
African (AFR)
AF:
AC:
864
AN:
41474
American (AMR)
AF:
AC:
978
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
451
AN:
3468
East Asian (EAS)
AF:
AC:
29
AN:
5164
South Asian (SAS)
AF:
AC:
155
AN:
4814
European-Finnish (FIN)
AF:
AC:
1280
AN:
10550
Middle Eastern (MID)
AF:
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7656
AN:
67944
Other (OTH)
AF:
AC:
145
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
539
1079
1618
2158
2697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
96
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.